Clinical trial

Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer

NCT00577356

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-02-01

PhasePHASE2

Study timeline

Study start (unknown)2008-02-01Date precision: month

Registry last updated2011-01-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

DocetaxelDRUG · verified · RxNorm: docetaxel

CG1940/CG8711BIOLOGICAL

Sponsors & collaborators

Benaroya Research Institutelead sponsor

Cell Genesyscollaborator

Sanoficollaborator

Mapped research locations

SeattleWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00577356 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.